Skip to search formSkip to main contentSkip to account menu

AGN 195183

Known as: AGN195183 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Retinoids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Antagonizing Retinoic Acid Receptors Increases Myeloid Cell Production by Cultured Human Hematopoietic Stem Cells
Activities of the retinoic acid receptor (RAR)α and RARγ are important to hematopoiesis. Here, we have investigated the effects… 
2004
2004
A phase I and pharmacokinetic clinical trial of the orally administered retinoic acid receptor-α Agonist, AGN 195183.
2022 Background: AGN 195183 is a novel retinoid that trans-activates retinoic acid receptor-α (RAR-α). In preclinical models, AGN… 
Highly Cited
2004
Highly Cited
2004
Retinoic acid receptor α and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat
Retinoids, derivatives of vitamin A, inhibit mesangial cell proliferation, glomerular inflammation, and extracellular matrix… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)